Outlandish prediction time. Looking at a chart I see a 1-2 day move to $7.60 coming. This has been a rare stoney crap out but I still have a lot faith in the name. Limelight Networks, Inc. (LLNW) NasdaqGS - NasdaqGS Real Time Price. Currency in USD $4.6500+0.0300 (+0.65%) At close: 4:00PM EST
ADOM up 30% yesterday with high volume and no news.... maybe a decision from HVIP coming? big order in the works??
GUMMY ALERT Pretty sure today will be a great day to get long SNAP in the pre-market here. It's at $53.25 Remember this? When I said these kids are bored out of their minds at home.... Well, not apples to apples... but pretty close. Check out what Tik-Tok reported from last night. Revenue friggin doubled! Profit went from 4B to 7B. _________________________________ TikTok’s Owner Doubles Sales to $35 Billion Despite U.S. Ban January 27, 2021, 2:32 AM EST ByteDance Ltd.’s revenue more than doubled to about $35 billion last year, defying heightened global competition and Trump’s attempt to ban its signature video service TikTok in the U.S. The Chinese company managed to grow operating profit to roughly $7 billion in 2020 from less than $4 billion the prior year, a person familiar with the matter said. That’s in a year when former U.S. president Donald Trump sought to ban TikTok and force its sale to American investors led by Oracle Corp. With Joe Biden in office, the company is moving closer toward listing part of its social media empire in Hong Kong. The Information first reported on ByteDance’s 2020 financials. ByteDance’s phenomenal growth stems from the global success of teen phenom TikTok and its Chinese twin Douyin, which helped pioneer a new form of social video and undercut rivals from Facebook Inc. to Tencent Holdings Ltd. Last valued at about $180 billion, the company is said to be exploring an initial public offering for some of its businesses in Hong Kong, including Douyin. A ByteDance spokesperson declined to comment. $SNAP IS A PRE-MARKET GUMMY BUY!!!! ____________________________EDIT__________________________ But wait, there's more. This just came out too. Snap acquires Ariel AI, a computer vision startup set up by ex-Facebook and Google scientists Snap, the parent company of social media app Snapchat, has acquired a British artificial intelligence start-up called Ariel AI which focuses on augmented reality. Ariel AI was founded in London in 2018 by a group of former Google and Facebook research scientists including Chief Executive Iasonas Kokkinos and Chief Technology Officer George Papandreou. LONDON — Snap, the parent company of social media app Snapchat, has acquired a British artificial intelligence start-up called Ariel AI which focuses on augmented reality. Ariel AI was founded in London in 2018 by a group of former Google and Facebook research scientists including Chief Executive Iasonas Kokkinos and Chief Technology Officer George Papandreou. The news was first reported by Business Insider and confirmed to CNBC by Snap on Tuesday. Ariel AI has been focusing on an area of AI known as computer vision, which is used to build augmented reality features. The start-up's website says that its software allows "3D human perception" in real time and that it can be used to power "the next generation of consumer experiences on mobile devices." A YouTube demo video shows how the company's technology can render a 3D model of a person in real time. The model can then be used for virtual clothes try-ons and immersive gaming. Snap said their work will focus on understanding geometry, semantics and more of what is in the field of view of the camera. Nathan Benaich, an AI investor at Air Street Capital and co-author of the annual State of AI report, told CNBC that he wasn't surprised Snap bought Ariel AI. "That was my bet actually," he said, adding that Facebook, Samsung, and Pokemon Go maker Niantic were other contenders for him. Benaich said he thinks Snap bought Ariel because it is "focused on on-device 3D mesh building in a snappy and battery efficient way with a use case in AR." He also said Snap probably also bought the company for the talent that it has across its workforce. Social media firms like TikTok and Facebook are battling it out to develop the most sophisticated AR experiences for their users. These range from dog ears that people can superimpose on top of their heads to other special effects. U.S. tech firms have acquired several British AI start-ups in recent years. The best-known example is Google buying DeepMind for a reported $600 million in 2014. Elsewhere, Twitter bought Magic Pony Technology for $150 million, while Facebook bought Bloomsbury AI in a deal worth up to $30 million. Snap also bought a start-up called Voisey last November, which has developed an app that allows people to overlay their own voice on short music tracks. PRE-MARKET GUMMY BUY!!!!
Stoney, we were wrong on that earnings date. Its 2/4. One of the best and most reliable T/A setups there is. Check it out. The esteemed ascending wedge. 6 month daily:
Ariel AI has been focusing on an area of AI known as computer vision, which is used to build augmented reality features. The start-up's website says that its software allows "3D human perception" in real time and that it can be used to power "the next generation of consumer experiences on mobile devices." A YouTube demo video shows how the company's technology can render a 3D model of a person in real time. The model can then be used for virtual clothes try-ons and immersive gaming. = $$$$$$$$$$$$$$$$$$
Good Morning-- Warning sign emerges. Biden and team has greatly increased the Moderna and Pfizer order for vax. Why would they do that with huge J&J out there about to reveal their statistics? J&J reported earnings yesterday why would they not reveal partial numbers? Taken together I am afraid J&J might have poor results. I own quite a bit of J&J and will have to really think about this today. For the market this would be a big blow. Everyone is counting on a new player in the vax game and J&J was supposed to be that player.~stoney
Canopy Growth CEO on Launch of CBD Beverage Line Quatreau: ‘Our First Foray Into Mood Modulation’ Dubbed Quatreau, the Sparkling Waters Represent the Company’s First Incursion Into the CBD Beverages Market in Canada Less than 48 hours after informing it would move its U.S. stock listing from theNew York Stock Exchange (NYSE)to the NASDAQ Exchange, Canadian cannabis giant Canopy Growth(NASDAQ:CGC) announced the launch of a new line of CBD-infused beverages.
Why the Creso Pharma Share Price is Smoking the Market Today Creso Pharma’s Stock is on the Move Following a Recent Announcement That the Company Secured a New Purchase Order for its Leading Range of Animal Health Products Anibidiol According to the Creso Pharma(OTC: COPHF) press release, the order has come from its existing commercial partner, Virbac Switzerland, and is a repeat of a previous order. The order is valued at CHF171,000 (A$247,826) and is expected to be delivered to Virbac Switzerland in April 2021. Management notes that this adds to a number of orders that Creso Pharma has secured in the recent weeks including three for anibidiol valued at CHF277,000 (A$401,4491) from current commercial partners. The company expects to fulfil these orders during the current quarter, with the sale to be banked shortly after. In addition to this, Creso Pharma advised that it is also witnessing strong demand for its products in Latin America.
Cresco is super cheap and low vol candidate. Cresco Labs Inc.: Cresco Labs is a consumer-packaged cannabis products company involved in growing, manufacturing, and distribution. The company currently operates in nine states, and owns a large number of production facilities and dispensaries, and holds 29 retail licenses.13 Its brands include Cresco, Reserve, Remedi, Mindy's, Good News, High Supply, Wonder Wellness Co., and FloraCal Farms.14 Cresco Labs announced recently that it has hired Ty Gent to serve as the company's new chief operating officer (COO). Gent has more than 35 years of consumer packaged goods (CPG) and supply chain leadership experience and most recently served as the chief supply chain officer at U.S. Foods Holding Corp.
my vaccine stock is novavax NVAX and we're expecting UK / south africa results in the next week or two, and the whole stock i think is relying on that data. the US study is in phase three (I joined the trial!), so it's lagging and is not necessarily going to come to the rescue if results are good, esp in the US, but other countries are buying it. canada just bought a heap of it. that doesn't respond to your J&J directly, but it's also on my mind. this world is going to need more vaccines to come through, esp for the poorer countries who haven't been able to elbow in, and also different kinds of vaccines, because one kind might adapt to mutations better, or might be better for the sick and elderly, etc, all of this i'm sure you're thinking about too...